Medication adherence and tolerability of Alzheimer's disease medications: study protocol for a randomized controlled trial.

Trials

Volumn 14, Issue , 2013, Pages

  Campbell, Noll L ^a   Dexter, Paul ^b   Perkins, Anthony J ^b   Gao, Sujuan ^b   Li, Lang ^b   Skaar, Todd C ^b   Frame, Amie ^b   Hendrie, Hugh C ^b   Callahan, Chris M ^b   Boustani, Malaz A ^b  

^a PURDUE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; NOOTROPIC AGENT;

AGED; ALZHEIMER DISEASE; BRAIN; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; DRUG EFFECTS; DRUG INTERACTION; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; MALE; MEDICATION COMPLIANCE; MEMORY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PHARMACOGENETICS; POLYPHARMACY; PROSPECTIVE STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TIME; TREATMENT OUTCOME; UNITED STATES;

AGED; ALZHEIMER DISEASE; BRAIN; CHOLINESTERASE INHIBITORS; CLINICAL PROTOCOLS; COMORBIDITY; DRUG INTERACTIONS; FEMALE; HUMANS; INDIANA; MALE; MEDICATION ADHERENCE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PHARMACOGENETICS; POLYPHARMACY; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891677331     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-125     Document Type: Article

References (0)